中草药

基于PI3K/Akt/mTOR信号通路研究巴戟天环烯醚萜类部位治疗衰老性肌少症的作用及机制

PDF下载

王馨莹 ¹, , 何晶晶 ¹, , 连晓笛 ¹, , 李慧 ¹,,², , 蔡雪婷 ¹,,², , 李瑶 ¹,,², , 范永春 ¹,,², , 赵呈雷 ¹,,²,

中草药 | 药理与临床 2026,57(16): 6385-6400

收起

中草药 |药理与临床 2026 , 57 (16) : 6385 -6400

基于PI3K/Akt/mTOR信号通路研究巴戟天环烯醚萜类部位治疗衰老性肌少症的作用及机制

全屏

王馨莹¹,, 何晶晶¹,, 连晓笛¹,, 李慧¹,,²,, 蔡雪婷¹,,²,, 李瑶¹,,²,, 范永春¹,,²,, 赵呈雷¹,,²,

作者信息

^1.南京中医药大学附属中西医结合医院, 江苏南京 210028

^2.江苏省中医药研究院, 江苏南京 210028

^3.南京中医药大学附属中西医结合医院, 江苏南京 210028

^4.江苏省中医药研究院, 江苏南京 210028

通讯作者:

赵呈雷

作者简介:

王馨莹: 王馨莹,硕士研究生,研究方向为中药效应与安全评价方法。E-mail:972074103@qq.com

Effect and mechanism of Morinda officinalis iridoid fraction in treatment of aging-related sarcopenia based on PI3K/Akt/mTOR signaling pathway

Affiliations

出版时间: 2026-08-28 doi: 10.7501/j.issn.0253-2670.2026.16.014

文章导航

摘要

收起

目的探讨巴戟天Morinda officinalis中环烯醚萜类部位对衰老性肌少症的治疗作用及机制。方法以水晶兰苷和去乙酰基车叶草苷酸为指标，考察不同体积分数乙醇对巴戟天中环烯醚萜类部位加热回流提取效率的影响，提取液经减压浓缩后，采用大孔吸附树脂富集纯化，获得总环烯醚萜类部位。通过比较不同极性洗脱溶剂的洗脱效果，优化纯化工艺参数，建立并验证高效液相色谱（high performance liquid chromatography，HPLC）分析方法后，对有效部位中主要环烯醚萜类成分进行含量测定，所得纯化部位用于后续药效学评价。利用C2C12细胞分化模型及D-半乳糖（D-galactose，D-gal）诱导的C2C12肌管细胞萎缩模型，以肌球蛋白重链（myosin heavy chain，MYHC）蛋白表达为指标，评价环烯醚萜类部位促进肌管分化及改善C2C12细胞肌管萎缩的作用。采用D-gal诱导的小鼠加速衰老模型，测量小鼠拉力及后肢肌肉质量，苏木素-伊红（hematoxylin-eosin，HE）染色观察胫骨前肌及腓肠肌病理变化，研究环烯醚萜类部位的治疗效果。利用转录组测序对各组小鼠腓肠肌进行差异基因分析，并综合网络药理学分析提示，进一步通过Western blotting及qRT-PCR验证转录组测序结果中相关差异基因表达变化。结果 60%乙醇加热回流提取巴戟天，环烯醚萜类部位含量最高。纯化工艺中，H103大孔吸附树脂吸附性能最佳，且以水为洗脱溶剂时目标成分洗脱率最高。巴戟天环烯醚萜类部位能显著改善D-gal诱导的C2C12细胞萎缩（P＜0.001），并促进肌管细胞分化（P＜0.05、0.01、0.001）。环烯醚萜类部位可显著提高加速衰老小鼠的四肢拉力和后肢肌肉质量与体质量比值（P＜0.05、0.01、0.001），显著增加衰老小鼠胫骨前肌和腓肠肌肌肉横截面积（P＜0.01、0.001），进而改善衰老相关的肌少症表型。进一步机制研究发现，环烯醚萜类部位可上调磷脂酰肌醇3-激酶（phosphatidylinositol 3-kinase，PI3K）/蛋白激酶B（protein kinase B，Akt）/哺乳动物雷帕霉素靶蛋白（mammalian target of rapamycin，mTOR）信号通路关键蛋白的表达水平（P＜0.05、0.01、0.001），并显著上调磷脂酰肌醇-4,5-二磷酸3激酶催化亚基α（phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha，PIK3CA）、丝氨酸/苏氨酸激酶1（serine/threonine kinase 1，AKT1）、mTOR基因表达水平（P＜0.05、0.01、0.001），且PI3K抑制剂LY294002显著抑制环烯醚萜类部位对PI3K/Akt/mTOR信号通路相关蛋白表达的上调作用（P＜0.05）。结论巴戟天中环烯醚萜类部位可显著改善衰老引起的肌少症，其作用机制与调控PI3K/Akt/mTOR信号通路有关。

关键词

肌少症 / 巴戟天 / 环烯醚萜类 / 衰老 / PI3K/Akt/mTOR信号通路 / 水晶兰苷 / 去乙酰基车叶草苷酸

Abstract

收起

Objective To investigate the therapeutic effect and mechanism of iridoid fraction from Morinda officinalis on aging-related sarcopenia. Methods Using monotropein and deacetylasperulosidic acid as analytical markers, effects of different ethanol concentrations on extraction efficiency of active iridoids fraction from M. officinalis via heated reflux extraction was investigated. The extract was concentrated under reduced pressure and subsequently enriched and purified using macroporous adsorption resin to obtain the total active iridoid fraction. By comparing the elution efficiencies of solvents with varying polarities, purification parameters were optimized. Following the establishment and validation of a high performance liquid chromatography (HPLC) analytical method, the content of major iridoid components in active fraction was quantified. The purified fraction was then used for subsequent pharmacodynamic evaluations. The C2C12 cell differentiation model and a D-galactose (D-gal)-induced C2C12 myotube atrophy model were employed to assess the effects of iridoid fraction on promoting myotube differentiation and ameliorating myotube atrophy, with MYHC protein expression serving as the indicator. A D-gal-induced accelerated aging mouse model was utilized to evaluate the therapeutic effects of iridoid fraction through grip strength tests, hindlimb muscle mass measurements, and hematoxylin-eosin (HE) staining of tibialis anterior and gastrocnemius muscles. Differentially expressed genes in gastrocnemius muscle of mice in each group was analyzed by transcriptome sequencing, and the results were further verified by Western blotting and qRT-PCR for the expression changes of related differentially expressed genes indicated by transcriptome sequencing, in combination with network pharmacology analysis. Results The extraction of iridoid components from M. officinalis was optimized using a 60% ethanol solution under heated reflux conditions, resulting in the highest iridoid content. In the purification process, H103 macroporous adsorption resin demonstrated superior adsorption performance, with water as the eluent resulting in the highest elution rate of target constituents. The iridoid fraction from M. officinalis significantly ameliorated D-gal-induced atrophy in C2C12 myotubes (P < 0.001), and promoted myotube differentiation (P < 0.05, 0.01, 0.001). The iridoid fraction could significantly enhance the limb pulling force and ratio of hind limb muscle mass to body mass of accelerated aging mice (P < 0.05, 0.01, 0.001), significantly increase the cross-sectional area of the tibialis anterior muscle and gastrocnemius muscle in aging mice (P < 0.01, 0.001), thereby improving the phenotype of age-related sarcopenia. Further mechanism studies revealed that iridoid fraction could up-regulate the expression levels of key proteins in phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) signaling pathway (P < 0.05, 0.01, 0.001), and significantly up-regulate the expression levels of phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA), serine/threonine kinase 1 (AKT1) and mTOR genes (P < 0.05, 0.01, 0.001). And PI3K inhibitor LY294002 significantly inhibited the upregulation of PI3K/Akt/mTOR signaling pathway related protein expressions by iridoid fraction (P < 0.05). Conclusion The iridoid fraction of M. officinalis can significantly improve sarcopenia caused by aging, and its mechanism is related to the regulation of PI3K/Akt/mTOR signaling pathway.

Key words

sarcopenia / Morinda officinalis How / iridoids / aging / PI3K/Akt/mTOR signaling pathway / monotropein / deacetylasperulosidic acid

引用本文

王馨莹, 何晶晶, 连晓笛, 李慧, 蔡雪婷, 李瑶, 范永春, 赵呈雷. 基于PI3K/Akt/mTOR信号通路研究巴戟天环烯醚萜类部位治疗衰老性肌少症的作用及机制. 中草药, 2026 , 57 (16) : 6385 -6400 . DOI: 10.7501/j.issn.0253-2670.2026.16.014

WANG Xinying, HE Jingjing, LIAN Xiaodi, LI Hui, CAI Xueting, LI Yao, FAN Yongchun, ZHAO Chenglei. Effect and mechanism of Morinda officinalis iridoid fraction in treatment of aging-related sarcopenia based on PI3K/Akt/mTOR signaling pathway[J]. Chinese Traditional and Herbal Drugs, 2026 , 57 (16) : 6385 -6400 . DOI: 10.7501/j.issn.0253-2670.2026.16.014

基金

收起

江苏省医院中药制剂融合创新中心项目
江苏省老年健康项目
南京中医药大学自然科学基金重点项目

参考文献

收起

文献

收起

参考文献引证文献

排序方式：

夏宇阳, 李扬, 何启旺, 等. 基于PI3K/Akt信号通路探究葛根素改善肌少症小鼠骨骼肌细胞衰老与线粒体功能障碍的机制[J]. 药物评价研究, 2026, 49(1): 144-155.

Vanni S, Colini Baldeschi A, Zattoni M, et al. Brain aging: A Ianus-faced player between health and neurodegeneration [J]. J Neurosci Res, 2020, 98(2): 299-311.

Kedlian V R, Wang Y N, Liu T L, et al. Human skeletal muscle aging atlas [J]. Nat Aging, 2024, 4(5): 727-744.

Xekouki P, Azevedo M, Stratakis C A. Anterior pituitary adenomas: Inherited syndromes, novel genes and molecular pathways [J]. Expert Rev Endocrinol Metab, 2010, 5(5): 697-709.

Glass D J. Signalling pathways that mediate skeletal muscle hypertrophy and atrophy [J]. Nat Cell Biol, 2003, 5(2):87-90.

Han M J, Choung S Y. Codonopsis lanceolata ameliorates sarcopenic obesity via recovering PI3K/Akt pathway and lipid metabolism in skeletal muscle [J]. Phytomedicine, 2022, 96: 153877.

邓斌, 刘温华, 宋银枝, 等. 从脾肾论治慢性心力衰竭肌少症之机理探讨[J]. 中国中医基础医学杂志, 2021, 27(8):1313-1315.

陈嘉敏. 老年肌肉减少症中医证型与相关影响因素研究[D]. 北京: 北京中医药大学, 2018.

沈燚, 何玉琼, 张奇, 等. 巴戟天环烯醚萜苷类成分的制备及其对破骨细胞骨吸收的抑制作用[J]. 第二军医大学学报, 2019, 40(2): 149-156.

Zhang J H, Xin H L, Xu Y M, et al. Morinda officinalis How.-A comprehensive review of traditional uses, phytochemistry and pharmacology [J]. J Ethnopharmacol, 2018, 213: 230-255.

Kim I T, Park H J, Nam J H, et al. In-vitro and in-vivo anti-inflammatory and antinociceptive effects of the methanol extract of the roots of Morinda officinalis [J]. J Pharm Pharmacol, 2005, 57(5): 607-615.

Zhang H L, Li J, Xia J M, et al. Antioxidant activity and physicochemical properties of an acidic polysaccharide from Morinda officinalis [J]. Int J Biol Macromol, 2013, 58:7-12.

刘梦云, 闫小景, 王宸, 等. 基于多指标-响应面法优选甘草制巴戟天工艺及其总寡糖体外抗氧化活性研究[J]. 中草药, 2024, 55(23):7989-7998.

李茂星, 贾正平, 沈涛, 等. 分光光度法测定藏药独一味及其制剂中总环烯醚萜苷的含量[J]. 中药新药与临床药理, 2006, 17(1): 45-47.

Wang P, Kang S Y, Kim S J, et al. Monotropein improves dexamethasone-induced muscle atrophy via the Akt/ mTOR/FOXO3a signaling pathways [J]. Nutrients, 2022, 14(9): 1859.

何盼, 陈磊, 连让平, 等. 中医药防治肌少症的研究进展[J]. 中草药, 2025, 56(10): 3729-3738.

Sayer A A, Syddall H, Martin H, et al. The developmental origins of sarcopenia [J]. J Nutr Health Aging, 2008, 12(7): 427-432.

Buford T W, Anton S D, Judge A R, et al. Models of accelerated sarcopenia: Critical pieces for solving the puzzle of age-related muscle atrophy [J]. Ageing Res Rev, 2010, 9(4): 369-383.

Wilkinson D J, Piasecki M, Atherton P J. The age-related loss of skeletal muscle mass and function: Measurement and physiology of muscle fibre atrophy and muscle fibre loss in humans [J]. Ageing Res Rev, 2018, 47: 123-132.

汪涛, 杨敏春, 任璇璇. 老年骨骼肌减少症中医理法探究[J]. 新中医, 2017, 49(11): 149-151.

Zhang Z W, Gao C S, Zhang H, et al. Morinda officinalis oligosaccharides increase serotonin in the brain and ameliorate depression via promoting 5-hydroxytryptophan production in the gut microbiota [J]. Acta Pharm Sin B, 2022, 12(8): 3298-3312.

Zhang Q, Zhang J H, He Y Q, et al. Iridoid glycosides from Morinda officinalis How. exert anti-inflammatory and anti-arthritic effects through inactivating MAPK and NF-κB signaling pathways [J]. BMC Complementary Med Ther, 2020, 20(1): 172.

Cordiano R, Caserta S, Minciullo P L, et al. Anthraquinones and Aloe vera extracts as potential modulators of inflammaging mechanisms: A translational approach from autoimmune to onco-hematological diseases [J]. Molecules, 2025, 30(6): 1251.

Glass D J. Skeletal muscle hypertrophy and atrophy signaling pathways [J]. Int J Biochem Cell Biol, 2005, 37(10):1974-1984.

McPherron A C, Lawler A M, Lee S J. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member [J]. Nature, 1997, 387(6628): 83-90.

Li H, Malhotra S, Kumar A. Nuclear factor-kappa B signaling in skeletal muscle atrophy [J]. J Mol Med, 2008, 86(10):1113-1126.

Sandri M, Sandri C, Gilbert A, et al. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy [J]. Cell, 2004, 117(3):399-412.

Sandri M. Signaling in muscle atrophy and hypertrophy [J]. Physiology, 2008, 23(3): 160-170.

Burke R E, Levine D N, Zajac F E III, et al. Mammalian motor units: Physiological-histochemical correlation in three types in cat gastrocnemius [J]. Science, 1971, 174(4010): 709-712.

Johnson M A, Polgar J, Weightman D, et al. Data on the distribution of fibre types in thirty-six human muscles An autopsy study [J]. J Neurol Sci, 1973, 18(1): 111-129.

Lexell J, Taylor C C, Sjöström M. What is the cause of the ageing atrophy? Total number, size and proportion of different fiber types studied in whole vastus lateralis muscle from 15-to 83-year-old men [J]. J Neurol Sci, 1988, 84(2/3): 275-294.

夏宇阳, 李扬, 何启旺, 等. 基于PI3K/Akt信号通路探究葛根素改善肌少症小鼠骨骼肌细胞衰老与线粒体功能障碍的机制[J]. 药物评价研究, 2026, 49(1): 144-155.
Vanni S, Colini Baldeschi A, Zattoni M, et al. Brain aging: A Ianus-faced player between health and neurodegeneration [J]. J Neurosci Res, 2020, 98(2): 299-311.
Kedlian V R, Wang Y N, Liu T L, et al. Human skeletal muscle aging atlas [J]. Nat Aging, 2024, 4(5): 727-744.
Xekouki P, Azevedo M, Stratakis C A. Anterior pituitary adenomas: Inherited syndromes, novel genes and molecular pathways [J]. Expert Rev Endocrinol Metab, 2010, 5(5): 697-709.
Glass D J. Signalling pathways that mediate skeletal muscle hypertrophy and atrophy [J]. Nat Cell Biol, 2003, 5(2):87-90.
Han M J, Choung S Y. Codonopsis lanceolata ameliorates sarcopenic obesity via recovering PI3K/Akt pathway and lipid metabolism in skeletal muscle [J]. Phytomedicine, 2022, 96: 153877.
邓斌, 刘温华, 宋银枝, 等. 从脾肾论治慢性心力衰竭肌少症之机理探讨[J]. 中国中医基础医学杂志, 2021, 27(8):1313-1315.
陈嘉敏. 老年肌肉减少症中医证型与相关影响因素研究[D]. 北京: 北京中医药大学, 2018.
沈燚, 何玉琼, 张奇, 等. 巴戟天环烯醚萜苷类成分的制备及其对破骨细胞骨吸收的抑制作用[J]. 第二军医大学学报, 2019, 40(2): 149-156.
Zhang J H, Xin H L, Xu Y M, et al. Morinda officinalis How.-A comprehensive review of traditional uses, phytochemistry and pharmacology [J]. J Ethnopharmacol, 2018, 213: 230-255.
Kim I T, Park H J, Nam J H, et al. In-vitro and in-vivo anti-inflammatory and antinociceptive effects of the methanol extract of the roots of Morinda officinalis [J]. J Pharm Pharmacol, 2005, 57(5): 607-615.
Zhang H L, Li J, Xia J M, et al. Antioxidant activity and physicochemical properties of an acidic polysaccharide from Morinda officinalis [J]. Int J Biol Macromol, 2013, 58:7-12.
刘梦云, 闫小景, 王宸, 等. 基于多指标-响应面法优选甘草制巴戟天工艺及其总寡糖体外抗氧化活性研究[J]. 中草药, 2024, 55(23):7989-7998.
李茂星, 贾正平, 沈涛, 等. 分光光度法测定藏药独一味及其制剂中总环烯醚萜苷的含量[J]. 中药新药与临床药理, 2006, 17(1): 45-47.
Wang P, Kang S Y, Kim S J, et al. Monotropein improves dexamethasone-induced muscle atrophy via the Akt/ mTOR/FOXO3a signaling pathways [J]. Nutrients, 2022, 14(9): 1859.
何盼, 陈磊, 连让平, 等. 中医药防治肌少症的研究进展[J]. 中草药, 2025, 56(10): 3729-3738.
Sayer A A, Syddall H, Martin H, et al. The developmental origins of sarcopenia [J]. J Nutr Health Aging, 2008, 12(7): 427-432.
Buford T W, Anton S D, Judge A R, et al. Models of accelerated sarcopenia: Critical pieces for solving the puzzle of age-related muscle atrophy [J]. Ageing Res Rev, 2010, 9(4): 369-383.
Wilkinson D J, Piasecki M, Atherton P J. The age-related loss of skeletal muscle mass and function: Measurement and physiology of muscle fibre atrophy and muscle fibre loss in humans [J]. Ageing Res Rev, 2018, 47: 123-132.
汪涛, 杨敏春, 任璇璇. 老年骨骼肌减少症中医理法探究[J]. 新中医, 2017, 49(11): 149-151.
Zhang Z W, Gao C S, Zhang H, et al. Morinda officinalis oligosaccharides increase serotonin in the brain and ameliorate depression via promoting 5-hydroxytryptophan production in the gut microbiota [J]. Acta Pharm Sin B, 2022, 12(8): 3298-3312.
Zhang Q, Zhang J H, He Y Q, et al. Iridoid glycosides from Morinda officinalis How. exert anti-inflammatory and anti-arthritic effects through inactivating MAPK and NF-κB signaling pathways [J]. BMC Complementary Med Ther, 2020, 20(1): 172.
Cordiano R, Caserta S, Minciullo P L, et al. Anthraquinones and Aloe vera extracts as potential modulators of inflammaging mechanisms: A translational approach from autoimmune to onco-hematological diseases [J]. Molecules, 2025, 30(6): 1251.
Glass D J. Skeletal muscle hypertrophy and atrophy signaling pathways [J]. Int J Biochem Cell Biol, 2005, 37(10):1974-1984.
McPherron A C, Lawler A M, Lee S J. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member [J]. Nature, 1997, 387(6628): 83-90.
Li H, Malhotra S, Kumar A. Nuclear factor-kappa B signaling in skeletal muscle atrophy [J]. J Mol Med, 2008, 86(10):1113-1126.
Sandri M, Sandri C, Gilbert A, et al. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy [J]. Cell, 2004, 117(3):399-412.
Sandri M. Signaling in muscle atrophy and hypertrophy [J]. Physiology, 2008, 23(3): 160-170.
Burke R E, Levine D N, Zajac F E III, et al. Mammalian motor units: Physiological-histochemical correlation in three types in cat gastrocnemius [J]. Science, 1971, 174(4010): 709-712.
Johnson M A, Polgar J, Weightman D, et al. Data on the distribution of fibre types in thirty-six human muscles An autopsy study [J]. J Neurol Sci, 1973, 18(1): 111-129.
Lexell J, Taylor C C, Sjöström M. What is the cause of the ageing atrophy? Total number, size and proportion of different fiber types studied in whole vastus lateralis muscle from 15-to 83-year-old men [J]. J Neurol Sci, 1988, 84(2/3): 275-294.

2026年第57卷第16期

PDF下载

124

引用本文

BibTeX

文章信息

doi: 10.7501/j.issn.0253-2670.2026.16.014

接收时间：2026-02-14
首发时间：2026-10-22
出版时间：2026-08-28

补充材料

相关文章

文章信息

作者

出版历史

收稿日期：2026-02-14

基金

江苏省医院中药制剂融合创新中心项目

江苏省老年健康项目

南京中医药大学自然科学基金重点项目

作者信息

^1.南京中医药大学附属中西医结合医院, 江苏南京 210028

^2.江苏省中医药研究院, 江苏南京 210028

^3.南京中医药大学附属中西医结合医院, 江苏南京 210028

^4.江苏省中医药研究院, 江苏南京 210028

通讯作者:

参考文献

分享链接

https://castjournals.cast.org.cn/joweb/zcy/CN/10.7501/j.issn.0253-2670.2026.16.014

分享至

全文二维码

扫描看全文

引用本文

BibTeX

本文的引用情况

2种不同金属材料的力学参数

科 Family	属数 Number of genus	种数 Number of species	占总种数比例 Percentage of total species (%)	属 Genus	种数 Number of species	占总种数比例 Percentage of total species (%)
鹅膏菌科Amanitaceae	2	11	5.26	鹅膏菌属 Amanita	10	4.78
小菇科 Mycenaceae	2	12	5.74	丝盖伞属 Inocybe	5	2.39
多孔菌科 Polyporaceae	8	14	6.70	蜡蘑属 Laccaria	5	2.39
红菇科 Russulaceae	3	23	11.00	小皮伞属 Marasmius	6	2.87
				小菇属 Mycena	11	5.26
				光柄菇属 Pluteus	5	2.39
				红菇属 Russula	17	8.13
				栓菌属 Trametes	5	2.39

关闭全屏

BibTeX
EndNote
RefWorks
TxT